Logo
DCA

Johnson & Johnson

sp500
JNJHealthcareDrug Manufacturers - General
$222.89
-0.28%
Last Price
$222.89
2026-06-02
24h Change
-0.28%
-0.62 USD
Volume
3.7M
Shares Traded
Data Reliability
High
16212 points (64 years)

Price History

Start a simulation with this asset

JNJ

Global parameters

Available data from 1/2/1962 to 6/2/2026

Fundamental Analysis

New
CAGR (5y)
5.60%
Revenue Growth
Net Margin
28.46%
Profitability
ROE
32.87%
Return on Equity
Debt / EBITDA
1.17
Solvency
PEG Ratio
2.99
Valuation vs Growth
Rev. Growth (TTM)
9.90%
Current Trend

PE Ratio History (5 Years)

Historical PE
Average (21.4x)
Current: 26.3x
Technical focus
JNJ
30d volatility
22.77%
Distance to MA50
-3.92%
Distance to MA200
4.96%
Distance to ATH
-10.33%
Momentum 3M
-9.14%
Risk score
N/A

Volatility moderate. Momentum neutral.

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Invest in this asset
Buy on Saxo Bank
🏦Regulated Broker
🌍Global Markets Access
📈Pro Tools

Ad link. Capital at risk.

Technical Analysis & Risk

Key Metrics

CAGR11.33%
Volatility22.77%
Max Drawdown-18.58%

Momentum : JNJ

Indicateur synthétique
PEURNEUTREAVIDITÉ
59
Greed

Risk Analysis

VaR (95%)-2.13%
DCA Health
95/100

Recent History (60 days)

DateCloseVolume
2026-06-02$222.893,676,189
2026-06-01$223.515,962,384
2026-05-29$225.336,188,580
2026-05-28$230.806,733,852
2026-05-27$231.295,835,500
2026-05-26$230.186,427,813
2026-05-22$234.345,460,721
2026-05-21$231.735,196,882
2026-05-20$229.323,376,613
2026-05-19$230.006,002,888
2026-05-18$228.929,222,828
2026-05-15$226.7111,232,375
2026-05-14$230.803,037,929
2026-05-13$230.425,327,127
2026-05-12$224.268,349,434
2026-05-11$221.433,625,123
2026-05-08$221.323,850,388
2026-05-07$222.516,771,465
2026-05-06$224.627,823,079
2026-05-05$225.555,271,298
2026-05-04$224.208,151,408
2026-05-01$227.196,022,437
2026-04-30$229.858,143,777
2026-04-29$227.356,884,458
2026-04-28$227.795,428,778
2026-04-27$225.345,498,001
2026-04-24$227.505,778,847
2026-04-23$230.656,947,896
2026-04-22$226.106,637,218
2026-04-21$226.1611,492,057
2026-04-20$230.697,751,452
2026-04-17$234.188,830,656
2026-04-16$234.548,561,323
2026-04-15$238.676,420,271
2026-04-14$240.1010,125,357
2026-04-13$237.965,353,143
2026-04-10$238.464,959,168
2026-04-09$241.314,337,851
2026-04-08$241.306,647,942
2026-04-07$238.414,750,813
2026-04-06$240.974,440,399
2026-04-02$243.045,282,963
2026-04-01$244.124,570,359
2026-03-31$244.444,863,682
2026-03-30$242.494,503,993
2026-03-27$240.455,772,651
2026-03-26$239.244,812,443
2026-03-25$239.936,454,367
2026-03-24$235.275,184,429
2026-03-23$235.427,301,338
2026-03-20$235.3717,149,592
2026-03-19$237.604,866,957
2026-03-18$237.286,678,607
2026-03-17$238.114,681,347
2026-03-16$243.194,606,588
2026-03-13$241.526,414,884
2026-03-12$242.047,696,685
2026-03-11$242.995,173,159
2026-03-10$243.717,214,100
2026-03-09$242.595,745,711

Recent Dividends

DateAmount
2026-02-24+$1.30
2025-11-25+$1.30
2025-08-26+$1.30
2025-05-27+$1.30
2025-02-18+$1.24
2024-11-26+$1.24
2024-08-27+$1.24
2024-05-20+$1.24
2024-02-16+$1.19
2023-11-20+$1.19
2023-08-25+$1.19
2023-05-22+$1.19
2023-02-17+$1.13
2022-11-21+$1.13
2022-08-22+$1.13
2022-05-23+$1.13
2022-02-18+$1.06
2021-11-22+$1.06
2021-08-23+$1.06
2021-05-24+$1.06

Related Assets